Cherepnalkovski Anet Papazovska, Zemunik Tatijana, Glamocanin Sofijanka, Piperkova Katica, Gunjaca Ivana, Kocheva Svetlana, Jovanova Biljana Coneska, Krzelj Vjekoslav
University Pediatric Clinic, Medical Faculty, University "St. Cyril and Methodius", Skopje, Republic of Macedonia.
Department of Medical Biology, School of Medicine, University of Split, Croatia.
Med Arch. 2015 Oct;69(5):284-8. doi: 10.5455/medarh.2015.69.284-288. Epub 2015 Oct 4.
Glucose-6-phospahte dehydrogenase deficiency (G6PD) is one of the most common inherited disorders affecting around 400 million people worldwide. Molecular analysis of the G6PD gene identified more than 140 distinct mutations, the majority being single base missense mutations. G6PD Mediterranean is the most common variant found in populations of the Mediterranean area.
The aim of our study was to perform molecular characterization of G6PD deficiency in families from the Republic of Macedonia and correlate the findings to disease phenotype.
Six patients and seven other family members were selected for genetic characterization, the selection procedure involved clinical evaluation and G6PD quantitative testing. All patients were first screened for the Mediterranean mutation, and subsequently for the Seattle mutation. Mutations were detected using PCR amplification and appropriate restriction endonuclease cleavage.
Four hemizygote and 3 heterozygous carriers for G6PD Mediterranean were detected. All G6PD deficient patients from this group showed clinical picture of hemolysis, and in 66.6% neonatal jaundice was confirmed based on history data. To our knowledge, this is the first study concerned with molecular aspects of the G6PD deficiency in R. Macedonia.
This study represents a step towards a more comprehensive genetic evaluation in our population and better understanding of the health issues involved.
葡萄糖-6-磷酸脱氢酶缺乏症(G6PD)是最常见的遗传性疾病之一,全球约有4亿人受其影响。对G6PD基因的分子分析发现了140多种不同的突变,其中大多数是单碱基错义突变。G6PD地中海型是在地中海地区人群中发现的最常见变体。
我们研究的目的是对来自马其顿共和国的家庭中的G6PD缺乏症进行分子特征分析,并将研究结果与疾病表型相关联。
选择6名患者和其他7名家庭成员进行基因特征分析,选择过程包括临床评估和G6PD定量检测。所有患者首先筛查地中海突变,随后筛查西雅图突变。使用PCR扩增和适当的限制性内切酶切割检测突变。
检测到4名G6PD地中海型半合子和3名杂合子携带者。该组所有G6PD缺乏症患者均表现出溶血的临床症状,根据病史资料,66.6%的患者确诊为新生儿黄疸。据我们所知,这是第一项关于马其顿共和国G6PD缺乏症分子方面的研究。
本研究朝着对我们人群进行更全面的基因评估以及更好地理解所涉及的健康问题迈出了一步。